Navigation Links
Defending against Tuberculosis

The deadliest bacterial pathogen may soon be fighting a losing battle. Scientists from Rockefeller University in New York say they have successfully stopped the tuberculosis pathogen's ability to operate from the immune system.// It typically hides out in the immune system in a cell called a macrophage.

The researchers say they have identified a new pathway (LRG-47) triggered by a host protein called interferon-gamma that disarms TB. Thus far, all of the research has been done in animals, but the researchers believe they have found a human equivalent of this pathway. They say LRG-47 is the correct pathway, because when they genetically remove it from the mice, they are then susceptible to TB infection.

According to experts, TB currently infects one-third of the human population and kills more people than any other bacterial pathogen. They write, "It is rivaled only by the acquired immunodeficiency syndrome (AIDS) virus as a communicable cause of death." Also, in developing countries, AIDS and TB go hand in hand. As many as 40 percent to 80 percent of AIDS patients will also develop TB.

Doctors know the protein interferon-gamma triggers a reaction of hundreds of genes, so they are still not quite sure which one is responsible for stopping TB. However, they say they are on the right path. One of the researchers, John McKinney, Ph.D. is quoted as saying: "One of the reasons we study the immune response to TB is to identify better treatments than those currently in use. This will occur only as a result of scientists' devoting more analysis to the bacteria's weaknesses and the host's strengths."

Page: 1

Related medicine news :

1. Multi billion-dollar suit filed against cell phone firm for causing brain tumours
2. Man against HIV – new vaccine ready for human trials
3. Antibiotics losing their power against acne
4. South Africa Wins landmark case against pharmaceutical giants
5. Vitamin E, the latest warrior against diabetes
6. Acne may protect against infections
7. Fight against E.coli
8. Defence against free radicals
9. Progestin protects against ovarian cancer
10. Beverage protect against bladder cancer
11. Moderate alcohol consumption protects against dementia
Post Your Comments:

(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: